| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histones | 96 | 2025 | 585 | 22.610 |
Why?
|
| Chromatin | 40 | 2025 | 477 | 9.420 |
Why?
|
| DNA-Binding Proteins | 38 | 2025 | 1421 | 8.420 |
Why?
|
| Histone Acetyltransferases | 20 | 2025 | 63 | 8.110 |
Why?
|
| Nucleosomes | 20 | 2025 | 137 | 6.660 |
Why?
|
| Protein Binding | 72 | 2025 | 2105 | 6.270 |
Why?
|
| Histone-Lysine N-Methyltransferase | 15 | 2025 | 125 | 5.770 |
Why?
|
| Lysine | 29 | 2023 | 282 | 5.690 |
Why?
|
| Epigenesis, Genetic | 23 | 2024 | 614 | 5.480 |
Why?
|
| Protein Processing, Post-Translational | 31 | 2022 | 451 | 5.480 |
Why?
|
| Protein Domains | 23 | 2025 | 252 | 5.370 |
Why?
|
| Transcription Factors | 30 | 2025 | 1628 | 5.200 |
Why?
|
| Nuclear Proteins | 16 | 2025 | 657 | 4.570 |
Why?
|
| Models, Molecular | 53 | 2025 | 1482 | 4.520 |
Why?
|
| PHD Zinc Fingers | 9 | 2024 | 13 | 4.330 |
Why?
|
| Saccharomyces cerevisiae Proteins | 14 | 2024 | 377 | 4.220 |
Why?
|
| Tumor Suppressor Proteins | 15 | 2025 | 313 | 3.460 |
Why?
|
| Protein Structure, Tertiary | 46 | 2017 | 835 | 3.370 |
Why?
|
| Acetylation | 31 | 2025 | 242 | 3.150 |
Why?
|
| Adenosine Triphosphatases | 6 | 2020 | 161 | 2.960 |
Why?
|
| Transcription Factor TFIID | 7 | 2024 | 25 | 2.950 |
Why?
|
| Binding Sites | 38 | 2024 | 1241 | 2.870 |
Why?
|
| Methylation | 35 | 2025 | 227 | 2.860 |
Why?
|
| Phosphatidylinositol Phosphates | 16 | 2011 | 39 | 2.650 |
Why?
|
| Homeodomain Proteins | 17 | 2024 | 489 | 2.470 |
Why?
|
| Crystallography, X-Ray | 24 | 2021 | 433 | 2.370 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 9 | 2017 | 25 | 2.340 |
Why?
|
| Repressor Proteins | 7 | 2025 | 399 | 2.280 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2023 | 153 | 2.160 |
Why?
|
| Histone Code | 10 | 2019 | 31 | 2.150 |
Why?
|
| DNA | 16 | 2025 | 1392 | 2.000 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2021 | 391 | 1.940 |
Why?
|
| Magnetic Resonance Spectroscopy | 20 | 2022 | 510 | 1.860 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2025 | 42 | 1.810 |
Why?
|
| Epigenomics | 3 | 2020 | 110 | 1.710 |
Why?
|
| Amino Acid Sequence | 32 | 2024 | 2042 | 1.710 |
Why?
|
| Saccharomyces cerevisiae | 11 | 2024 | 524 | 1.670 |
Why?
|
| DNA Helicases | 5 | 2023 | 149 | 1.670 |
Why?
|
| DNA Methylation | 9 | 2024 | 604 | 1.660 |
Why?
|
| Protein Conformation | 21 | 2021 | 853 | 1.650 |
Why?
|
| Zinc Fingers | 6 | 2020 | 43 | 1.590 |
Why?
|
| Humans | 135 | 2025 | 128019 | 1.480 |
Why?
|
| Autophagy | 5 | 2022 | 265 | 1.470 |
Why?
|
| Chromosomal Proteins, Non-Histone | 4 | 2025 | 115 | 1.460 |
Why?
|
| HEK293 Cells | 13 | 2024 | 681 | 1.400 |
Why?
|
| Protein Interaction Domains and Motifs | 10 | 2020 | 137 | 1.370 |
Why?
|
| Mitosis | 3 | 2017 | 178 | 1.360 |
Why?
|
| Embryonic Stem Cells | 3 | 2025 | 119 | 1.230 |
Why?
|
| Translocation, Genetic | 4 | 2023 | 95 | 1.180 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 18 | 2021 | 251 | 1.180 |
Why?
|
| Phosphatidylinositols | 7 | 2012 | 57 | 1.170 |
Why?
|
| Molecular Sequence Data | 25 | 2015 | 2820 | 1.160 |
Why?
|
| Cell Cycle Proteins | 8 | 2022 | 578 | 1.150 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 2 | 2025 | 14 | 1.140 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2016 | 504 | 1.130 |
Why?
|
| Mutation | 12 | 2025 | 3682 | 1.120 |
Why?
|
| Polycomb-Group Proteins | 7 | 2023 | 28 | 1.090 |
Why?
|
| Multiprotein Complexes | 3 | 2018 | 147 | 1.070 |
Why?
|
| Drug Design | 2 | 2020 | 155 | 1.070 |
Why?
|
| Sequestosome-1 Protein | 4 | 2022 | 13 | 1.030 |
Why?
|
| TATA-Binding Protein Associated Factors | 2 | 2024 | 19 | 1.020 |
Why?
|
| Polycomb Repressive Complex 2 | 2 | 2018 | 63 | 1.000 |
Why?
|
| Membrane Proteins | 11 | 2012 | 1105 | 0.990 |
Why?
|
| Animals | 44 | 2025 | 34487 | 0.980 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 337 | 0.980 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 333 | 0.970 |
Why?
|
| Gene Silencing | 2 | 2025 | 183 | 0.960 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2025 | 30 | 0.960 |
Why?
|
| Chromatin Assembly and Disassembly | 6 | 2022 | 101 | 0.960 |
Why?
|
| Calixarenes | 2 | 2015 | 6 | 0.950 |
Why?
|
| Gene Expression Regulation | 12 | 2023 | 2508 | 0.950 |
Why?
|
| Endogenous Retroviruses | 1 | 2025 | 34 | 0.930 |
Why?
|
| E1A-Associated p300 Protein | 2 | 2021 | 8 | 0.920 |
Why?
|
| Ubiquitin | 2 | 2022 | 62 | 0.910 |
Why?
|
| Drosophila Proteins | 3 | 2017 | 187 | 0.890 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2015 | 431 | 0.890 |
Why?
|
| p300-CBP Transcription Factors | 3 | 2025 | 21 | 0.880 |
Why?
|
| Dioxygenases | 1 | 2024 | 29 | 0.880 |
Why?
|
| SUMO-1 Protein | 2 | 2020 | 20 | 0.870 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2023 | 45 | 0.850 |
Why?
|
| Heterochromatin | 3 | 2025 | 41 | 0.830 |
Why?
|
| Acetyltransferases | 1 | 2023 | 22 | 0.830 |
Why?
|
| DNA Replication | 2 | 2023 | 225 | 0.820 |
Why?
|
| Thiazoles | 1 | 2023 | 115 | 0.820 |
Why?
|
| Diet | 2 | 2022 | 1198 | 0.820 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 3 | 2018 | 12 | 0.820 |
Why?
|
| Polyphenols | 1 | 2022 | 18 | 0.810 |
Why?
|
| Proteins | 4 | 2020 | 933 | 0.810 |
Why?
|
| Leukemia | 2 | 2023 | 228 | 0.800 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 5 | 2024 | 71 | 0.790 |
Why?
|
| Cell Nucleus | 3 | 2023 | 579 | 0.780 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2020 | 58 | 0.780 |
Why?
|
| DNA Repair | 7 | 2024 | 205 | 0.750 |
Why?
|
| Histidine | 7 | 2017 | 58 | 0.750 |
Why?
|
| Acute Disease | 2 | 2021 | 961 | 0.740 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2011 | 215 | 0.730 |
Why?
|
| Mice | 21 | 2025 | 16574 | 0.720 |
Why?
|
| Betacoronavirus | 2 | 2020 | 247 | 0.700 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2020 | 3 | 0.700 |
Why?
|
| Vesicular Transport Proteins | 9 | 2009 | 84 | 0.700 |
Why?
|
| Biochemistry | 1 | 2020 | 38 | 0.690 |
Why?
|
| Oligopeptides | 1 | 2022 | 255 | 0.690 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2020 | 36 | 0.680 |
Why?
|
| Leukemia, Myeloid | 1 | 2020 | 45 | 0.680 |
Why?
|
| Immune Evasion | 1 | 2020 | 55 | 0.680 |
Why?
|
| Macromolecular Substances | 1 | 2020 | 211 | 0.670 |
Why?
|
| Enzymes | 1 | 2020 | 64 | 0.670 |
Why?
|
| Phase Transition | 1 | 2019 | 24 | 0.670 |
Why?
|
| Transcription, Genetic | 11 | 2024 | 1403 | 0.660 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2025 | 1343 | 0.650 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 2041 | 0.650 |
Why?
|
| Cell Line, Tumor | 14 | 2021 | 3168 | 0.650 |
Why?
|
| Immunity, Innate | 2 | 2022 | 801 | 0.650 |
Why?
|
| Membrane Lipids | 3 | 2012 | 90 | 0.650 |
Why?
|
| Antiviral Agents | 3 | 2024 | 710 | 0.630 |
Why?
|
| Viral Vaccines | 1 | 2020 | 94 | 0.630 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 108 | 0.630 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2019 | 43 | 0.630 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2020 | 60 | 0.620 |
Why?
|
| Spectrometry, Fluorescence | 6 | 2020 | 171 | 0.620 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2020 | 198 | 0.620 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2024 | 591 | 0.610 |
Why?
|
| Neoplasms | 7 | 2024 | 2460 | 0.590 |
Why?
|
| Protein Structure, Secondary | 5 | 2013 | 340 | 0.580 |
Why?
|
| Promoter Regions, Genetic | 9 | 2025 | 1198 | 0.570 |
Why?
|
| Histone Deacetylases | 3 | 2016 | 210 | 0.570 |
Why?
|
| Colorectal Neoplasms | 1 | 2025 | 746 | 0.560 |
Why?
|
| Ligands | 5 | 2021 | 616 | 0.560 |
Why?
|
| Pyrans | 1 | 2017 | 5 | 0.550 |
Why?
|
| Antigens, Neoplasm | 2 | 2016 | 308 | 0.550 |
Why?
|
| Cell Plasticity | 1 | 2017 | 26 | 0.550 |
Why?
|
| Mutagenesis, Site-Directed | 10 | 2021 | 358 | 0.540 |
Why?
|
| Chromosome Segregation | 1 | 2017 | 40 | 0.540 |
Why?
|
| Histidine Kinase | 1 | 2016 | 33 | 0.530 |
Why?
|
| Protein Folding | 4 | 2017 | 266 | 0.520 |
Why?
|
| Molecular Dynamics Simulation | 5 | 2020 | 217 | 0.520 |
Why?
|
| Structure-Activity Relationship | 5 | 2025 | 538 | 0.520 |
Why?
|
| Morpholines | 1 | 2017 | 122 | 0.510 |
Why?
|
| Thiophenes | 1 | 2017 | 118 | 0.510 |
Why?
|
| Autoantigens | 4 | 2014 | 416 | 0.510 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 419 | 0.500 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 130 | 0.500 |
Why?
|
| Molecular Structure | 7 | 2021 | 465 | 0.500 |
Why?
|
| Cell Membrane | 4 | 2012 | 725 | 0.490 |
Why?
|
| Inositol Phosphates | 2 | 2012 | 22 | 0.490 |
Why?
|
| Fluorescence Polarization | 3 | 2021 | 38 | 0.490 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2023 | 875 | 0.480 |
Why?
|
| Pandemics | 2 | 2020 | 1473 | 0.480 |
Why?
|
| Carrier Proteins | 2 | 2018 | 730 | 0.480 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 2 | 2021 | 5 | 0.470 |
Why?
|
| Plant Proteins | 1 | 2015 | 88 | 0.470 |
Why?
|
| Signal Transduction | 9 | 2024 | 4812 | 0.470 |
Why?
|
| Lipid Bilayers | 4 | 2011 | 97 | 0.460 |
Why?
|
| Biomarkers, Tumor | 3 | 2016 | 1175 | 0.460 |
Why?
|
| Phosphorylation | 7 | 2016 | 1681 | 0.460 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 608 | 0.450 |
Why?
|
| Indicators and Reagents | 1 | 2014 | 106 | 0.450 |
Why?
|
| Protein Subunits | 4 | 2024 | 230 | 0.440 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2018 | 367 | 0.430 |
Why?
|
| Intracellular Membranes | 3 | 2011 | 82 | 0.420 |
Why?
|
| Molecular Docking Simulation | 3 | 2020 | 109 | 0.410 |
Why?
|
| Influenza, Human | 1 | 2019 | 600 | 0.410 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2023 | 63 | 0.390 |
Why?
|
| Cyclophilins | 2 | 2023 | 35 | 0.390 |
Why?
|
| Cell Differentiation | 2 | 2025 | 1896 | 0.390 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2017 | 541 | 0.390 |
Why?
|
| Micelles | 4 | 2006 | 37 | 0.380 |
Why?
|
| HMGN2 Protein | 1 | 2011 | 3 | 0.380 |
Why?
|
| Molecular Probes | 1 | 2011 | 37 | 0.380 |
Why?
|
| Recombinant Proteins | 4 | 2020 | 1286 | 0.370 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2011 | 3 | 0.370 |
Why?
|
| Static Electricity | 4 | 2020 | 115 | 0.370 |
Why?
|
| trans-Golgi Network | 1 | 2011 | 13 | 0.370 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2022 | 356 | 0.360 |
Why?
|
| Sequence Alignment | 8 | 2015 | 329 | 0.360 |
Why?
|
| Molecular Conformation | 2 | 2022 | 141 | 0.360 |
Why?
|
| Cell Line | 10 | 2024 | 2736 | 0.350 |
Why?
|
| Qc-SNARE Proteins | 3 | 2006 | 7 | 0.350 |
Why?
|
| RNA | 2 | 2023 | 881 | 0.350 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2020 | 634 | 0.340 |
Why?
|
| CpG Islands | 2 | 2023 | 151 | 0.340 |
Why?
|
| Viral Proteins | 2 | 2022 | 321 | 0.330 |
Why?
|
| Protein Multimerization | 3 | 2024 | 178 | 0.330 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2009 | 38 | 0.330 |
Why?
|
| Models, Biological | 7 | 2020 | 1689 | 0.320 |
Why?
|
| Transcriptional Elongation Factors | 2 | 2021 | 36 | 0.320 |
Why?
|
| Acylation | 2 | 2019 | 28 | 0.320 |
Why?
|
| Peptides | 6 | 2020 | 910 | 0.310 |
Why?
|
| Catalytic Domain | 3 | 2019 | 217 | 0.310 |
Why?
|
| Conserved Sequence | 5 | 2013 | 227 | 0.300 |
Why?
|
| Amino Acid Motifs | 8 | 2020 | 210 | 0.300 |
Why?
|
| Escherichia coli | 4 | 2020 | 766 | 0.300 |
Why?
|
| Ubiquitination | 2 | 2019 | 98 | 0.300 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 2 | 2007 | 29 | 0.300 |
Why?
|
| Carcinogenesis | 2 | 2021 | 209 | 0.290 |
Why?
|
| Kinetics | 3 | 2020 | 1617 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 4 | 2020 | 569 | 0.290 |
Why?
|
| Genetic Therapy | 1 | 2009 | 290 | 0.280 |
Why?
|
| HeLa Cells | 7 | 2017 | 605 | 0.280 |
Why?
|
| Small Molecule Libraries | 2 | 2021 | 86 | 0.280 |
Why?
|
| Apoptosis | 3 | 2023 | 2425 | 0.280 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2021 | 324 | 0.280 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 4 | 2015 | 186 | 0.280 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2007 | 43 | 0.280 |
Why?
|
| CREB-Binding Protein | 2 | 2019 | 27 | 0.280 |
Why?
|
| Methyltransferases | 2 | 2019 | 69 | 0.270 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2017 | 20 | 0.260 |
Why?
|
| Cell Cycle | 2 | 2020 | 580 | 0.260 |
Why?
|
| Histone Deacetylase 1 | 2 | 2017 | 24 | 0.250 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 809 | 0.250 |
Why?
|
| Substrate Specificity | 7 | 2013 | 366 | 0.250 |
Why?
|
| Crystallization | 2 | 2020 | 137 | 0.250 |
Why?
|
| Cytosol | 2 | 2021 | 215 | 0.240 |
Why?
|
| HCT116 Cells | 1 | 2025 | 78 | 0.240 |
Why?
|
| DNA Damage | 4 | 2015 | 363 | 0.240 |
Why?
|
| Tryptophan | 3 | 2020 | 171 | 0.230 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2025 | 30 | 0.230 |
Why?
|
| Virus Replication | 2 | 2024 | 444 | 0.220 |
Why?
|
| Endosomes | 2 | 2005 | 126 | 0.220 |
Why?
|
| Cloning, Molecular | 2 | 2020 | 522 | 0.220 |
Why?
|
| Phosphatidylethanolamines | 3 | 2011 | 74 | 0.220 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2023 | 19 | 0.210 |
Why?
|
| Tudor Domain | 3 | 2021 | 3 | 0.210 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2023 | 51 | 0.210 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2023 | 47 | 0.210 |
Why?
|
| Homologous Recombination | 1 | 2023 | 23 | 0.210 |
Why?
|
| Cells, Cultured | 4 | 2021 | 4006 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2024 | 632 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2024 | 176 | 0.210 |
Why?
|
| Biophysical Phenomena | 2 | 2021 | 64 | 0.210 |
Why?
|
| Plants | 2 | 2023 | 214 | 0.200 |
Why?
|
| Drosophila melanogaster | 2 | 2017 | 217 | 0.200 |
Why?
|
| Databases, Protein | 1 | 2021 | 62 | 0.190 |
Why?
|
| Peptidomimetics | 1 | 2021 | 3 | 0.190 |
Why?
|
| K562 Cells | 2 | 2019 | 82 | 0.190 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 145 | 0.180 |
Why?
|
| Recombination, Genetic | 3 | 2012 | 189 | 0.180 |
Why?
|
| Zinc Finger Nucleases | 1 | 2020 | 1 | 0.180 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2020 | 3 | 0.180 |
Why?
|
| S Phase Cell Cycle Checkpoints | 1 | 2020 | 4 | 0.180 |
Why?
|
| GATA4 Transcription Factor | 1 | 2020 | 18 | 0.180 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2021 | 83 | 0.180 |
Why?
|
| Buffers | 1 | 2020 | 55 | 0.180 |
Why?
|
| Chemical Fractionation | 1 | 2020 | 29 | 0.180 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2020 | 15 | 0.180 |
Why?
|
| Retinoblastoma-Binding Protein 2 | 1 | 2020 | 3 | 0.180 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2020 | 15 | 0.170 |
Why?
|
| Antigens, Nuclear | 1 | 2020 | 20 | 0.170 |
Why?
|
| Disulfiram | 1 | 2020 | 14 | 0.170 |
Why?
|
| Phosphoproteins | 3 | 2016 | 328 | 0.170 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2021 | 195 | 0.170 |
Why?
|
| Drug Discovery | 1 | 2021 | 130 | 0.170 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 66 | 0.170 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 50 | 0.170 |
Why?
|
| Cysteine Endopeptidases | 1 | 2020 | 67 | 0.170 |
Why?
|
| Fluorescence | 1 | 2020 | 160 | 0.170 |
Why?
|
| Mice, Knockout | 2 | 2025 | 2757 | 0.170 |
Why?
|
| Spectrum Analysis | 1 | 2020 | 86 | 0.170 |
Why?
|
| Protein Transport | 5 | 2005 | 420 | 0.160 |
Why?
|
| Phosphatidylcholines | 2 | 2011 | 146 | 0.160 |
Why?
|
| E2F1 Transcription Factor | 1 | 2019 | 61 | 0.160 |
Why?
|
| Virulence | 1 | 2020 | 252 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 1943 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 37 | 0.160 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2337 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 281 | 0.160 |
Why?
|
| Synaptosomal-Associated Protein 25 | 4 | 2006 | 26 | 0.160 |
Why?
|
| Genetic Vectors | 1 | 2020 | 311 | 0.160 |
Why?
|
| Binding, Competitive | 1 | 2019 | 204 | 0.160 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 108 | 0.150 |
Why?
|
| Drosophila | 2 | 2017 | 142 | 0.150 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 2327 | 0.150 |
Why?
|
| Sumoylation | 1 | 2018 | 16 | 0.150 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2017 | 131 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 443 | 0.150 |
Why?
|
| Life Expectancy | 1 | 2018 | 60 | 0.150 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2018 | 115 | 0.150 |
Why?
|
| Catalysis | 1 | 2019 | 305 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 221 | 0.140 |
Why?
|
| Phosphoric Monoester Hydrolases | 3 | 2010 | 53 | 0.140 |
Why?
|
| Xenopus | 1 | 2017 | 85 | 0.140 |
Why?
|
| Cell Survival | 2 | 2021 | 1073 | 0.140 |
Why?
|
| Enzyme Activation | 1 | 2019 | 796 | 0.140 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 317 | 0.130 |
Why?
|
| Cell Adhesion | 1 | 2018 | 444 | 0.130 |
Why?
|
| Arginine | 2 | 2023 | 259 | 0.130 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 355 | 0.130 |
Why?
|
| Aspartic Acid | 1 | 2016 | 78 | 0.130 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 492 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2017 | 1045 | 0.130 |
Why?
|
| Hydrogen Bonding | 3 | 2011 | 149 | 0.130 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 157 | 0.130 |
Why?
|
| Life Style | 1 | 2018 | 459 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 817 | 0.130 |
Why?
|
| Glutathione Transferase | 1 | 2016 | 99 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 2017 | 153 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 2 | 2007 | 380 | 0.120 |
Why?
|
| Histocompatibility Antigens | 1 | 2016 | 107 | 0.120 |
Why?
|
| Protein Stability | 1 | 2015 | 159 | 0.120 |
Why?
|
| Gene Expression | 1 | 2020 | 1454 | 0.120 |
Why?
|
| Human papillomavirus 18 | 1 | 2015 | 15 | 0.120 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2015 | 69 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 189 | 0.120 |
Why?
|
| Mice, Nude | 1 | 2017 | 675 | 0.120 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 110 | 0.120 |
Why?
|
| Human papillomavirus 16 | 1 | 2015 | 33 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2017 | 662 | 0.120 |
Why?
|
| Leucine | 2 | 2024 | 108 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 1 | 2016 | 132 | 0.120 |
Why?
|
| Plasmids | 1 | 2016 | 354 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 388 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2018 | 1140 | 0.120 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 85 | 0.120 |
Why?
|
| Glutamic Acid | 1 | 2016 | 228 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1663 | 0.110 |
Why?
|
| Spermatogenesis | 1 | 2014 | 62 | 0.110 |
Why?
|
| Algorithms | 1 | 2021 | 1609 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 2066 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 265 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 1813 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2016 | 822 | 0.100 |
Why?
|
| Dimerization | 2 | 2006 | 188 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 2131 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 3936 | 0.100 |
Why?
|
| Spindle Apparatus | 1 | 2013 | 93 | 0.100 |
Why?
|
| Molecular Chaperones | 1 | 2014 | 181 | 0.100 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 232 | 0.100 |
Why?
|
| Eukaryota | 1 | 2012 | 53 | 0.090 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2013 | 177 | 0.090 |
Why?
|
| Mutagenesis | 1 | 2011 | 181 | 0.090 |
Why?
|
| Escherichia coli Proteins | 2 | 2003 | 177 | 0.090 |
Why?
|
| Down Syndrome | 1 | 2016 | 469 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2014 | 688 | 0.080 |
Why?
|
| Phospholipids | 1 | 2011 | 207 | 0.080 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 122 | 0.080 |
Why?
|
| Biological Transport | 1 | 2011 | 396 | 0.080 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2012 | 221 | 0.080 |
Why?
|
| Genome | 1 | 2012 | 277 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 873 | 0.080 |
Why?
|
| SNARE Proteins | 2 | 2006 | 39 | 0.080 |
Why?
|
| Reference Standards | 1 | 2009 | 168 | 0.080 |
Why?
|
| Inhibitor of Growth Protein 1 | 1 | 2008 | 1 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2012 | 401 | 0.080 |
Why?
|
| Nitrogen Isotopes | 1 | 2008 | 58 | 0.070 |
Why?
|
| Pyridines | 1 | 2012 | 474 | 0.070 |
Why?
|
| VDJ Recombinases | 1 | 2007 | 4 | 0.070 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2007 | 7 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 56 | 0.070 |
Why?
|
| Phosphatidylserines | 1 | 2008 | 88 | 0.070 |
Why?
|
| Protons | 1 | 2008 | 80 | 0.070 |
Why?
|
| Carbon Isotopes | 1 | 2008 | 123 | 0.070 |
Why?
|
| ErbB Receptors | 2 | 2012 | 601 | 0.070 |
Why?
|
| COS Cells | 1 | 2007 | 184 | 0.070 |
Why?
|
| Embryo, Mammalian | 2 | 2020 | 226 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2006 | 6 | 0.060 |
Why?
|
| Valine | 1 | 2006 | 80 | 0.060 |
Why?
|
| Organothiophosphates | 1 | 2006 | 5 | 0.060 |
Why?
|
| Phosphopeptides | 1 | 2006 | 18 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 327 | 0.060 |
Why?
|
| src Homology Domains | 1 | 2006 | 37 | 0.060 |
Why?
|
| Spin Labels | 1 | 2005 | 46 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2006 | 257 | 0.060 |
Why?
|
| Mathematics | 1 | 2005 | 103 | 0.060 |
Why?
|
| Cell Movement | 1 | 2010 | 933 | 0.060 |
Why?
|
| Hydroxylamines | 1 | 2024 | 4 | 0.060 |
Why?
|
| Pyridones | 1 | 2006 | 158 | 0.060 |
Why?
|
| Cytidine | 1 | 2024 | 6 | 0.060 |
Why?
|
| Vero Cells | 1 | 2024 | 65 | 0.060 |
Why?
|
| Neutrophils | 1 | 2010 | 1192 | 0.060 |
Why?
|
| Virus Internalization | 1 | 2024 | 46 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2024 | 41 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2019 | 381 | 0.060 |
Why?
|
| Ligases | 1 | 2023 | 30 | 0.050 |
Why?
|
| Symporters | 1 | 2003 | 54 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 25 | 0.050 |
Why?
|
| Nucleocapsid | 1 | 2023 | 18 | 0.050 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 20 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2024 | 356 | 0.050 |
Why?
|
| Transfection | 1 | 2005 | 891 | 0.050 |
Why?
|
| Liposomes | 2 | 2007 | 168 | 0.050 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2002 | 13 | 0.050 |
Why?
|
| Stress Fibers | 1 | 2002 | 18 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2020 | 934 | 0.050 |
Why?
|
| Lipids | 1 | 2006 | 619 | 0.050 |
Why?
|
| Serine | 1 | 2023 | 135 | 0.050 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2001 | 3 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2022 | 126 | 0.050 |
Why?
|
| Autophagosomes | 1 | 2021 | 19 | 0.050 |
Why?
|
| Autophagy-Related Proteins | 1 | 2021 | 41 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2001 | 128 | 0.040 |
Why?
|
| Biological Assay | 1 | 2021 | 118 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 10 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 135 | 0.040 |
Why?
|
| Smad2 Protein | 1 | 2020 | 35 | 0.040 |
Why?
|
| Actins | 1 | 2002 | 401 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2023 | 430 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 569 | 0.040 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2019 | 2 | 0.040 |
Why?
|
| DNA, Superhelical | 1 | 1999 | 11 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 134 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 61 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2000 | 136 | 0.040 |
Why?
|
| Structural Homology, Protein | 2 | 2011 | 25 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 52 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 328 | 0.040 |
Why?
|
| Oncogenes | 1 | 2020 | 109 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2019 | 76 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 380 | 0.040 |
Why?
|
| Rats | 1 | 2007 | 5199 | 0.040 |
Why?
|
| Molecular Weight | 1 | 1999 | 331 | 0.040 |
Why?
|
| Solubility | 1 | 1999 | 232 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 620 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 1999 | 323 | 0.040 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2017 | 19 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 270 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1999 | 322 | 0.030 |
Why?
|
| Female | 4 | 2017 | 68016 | 0.030 |
Why?
|
| Membranes, Artificial | 2 | 2011 | 69 | 0.030 |
Why?
|
| Xenopus laevis | 2 | 2010 | 96 | 0.030 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2016 | 2 | 0.030 |
Why?
|
| F-Box Proteins | 1 | 2016 | 26 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 50 | 0.030 |
Why?
|
| Zinc | 1 | 1999 | 292 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 115 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 128 | 0.030 |
Why?
|
| Locus Control Region | 1 | 2015 | 2 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 370 | 0.030 |
Why?
|
| Acetylglucosamine | 1 | 2015 | 10 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 323 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 633 | 0.030 |
Why?
|
| Glycosylation | 1 | 2015 | 149 | 0.030 |
Why?
|
| Prophase | 1 | 2014 | 1 | 0.030 |
Why?
|
| Chromosome Pairing | 1 | 2014 | 4 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 371 | 0.030 |
Why?
|
| Meiosis | 1 | 2014 | 63 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 1047 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 940 | 0.030 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2014 | 59 | 0.030 |
Why?
|
| Base Sequence | 2 | 2012 | 2134 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 133 | 0.030 |
Why?
|
| CD79 Antigens | 1 | 2012 | 15 | 0.030 |
Why?
|
| PAX5 Transcription Factor | 1 | 2012 | 14 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 484 | 0.030 |
Why?
|
| Receptors, Antigen | 1 | 2012 | 15 | 0.020 |
Why?
|
| p21-Activated Kinases | 1 | 2011 | 15 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2012 | 54 | 0.020 |
Why?
|
| Systems Biology | 1 | 2012 | 59 | 0.020 |
Why?
|
| ras Proteins | 1 | 2012 | 144 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 169 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 258 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2012 | 274 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 5268 | 0.020 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2010 | 4 | 0.020 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2010 | 12 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 115 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 181 | 0.020 |
Why?
|
| Peptide Library | 1 | 2010 | 83 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3874 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2011 | 315 | 0.020 |
Why?
|
| Hippocampus | 1 | 2014 | 801 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2010 | 157 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 463 | 0.020 |
Why?
|
| Cattle | 1 | 2010 | 962 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 595 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2007 | 62 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 812 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 744 | 0.020 |
Why?
|
| Metabolomics | 1 | 2012 | 599 | 0.020 |
Why?
|
| Inositol | 1 | 2006 | 26 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2006 | 36 | 0.020 |
Why?
|
| Myristic Acid | 1 | 2006 | 10 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 1445 | 0.020 |
Why?
|
| Proteomics | 1 | 2012 | 1008 | 0.020 |
Why?
|
| Point Mutation | 1 | 2006 | 221 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 2006 | 79 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 2598 | 0.010 |
Why?
|
| Solutions | 1 | 2003 | 148 | 0.010 |
Why?
|
| Dishevelled Proteins | 1 | 2002 | 2 | 0.010 |
Why?
|
| Axin Protein | 1 | 2002 | 18 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 35 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 151 | 0.010 |
Why?
|
| Proteome | 1 | 2006 | 430 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 276 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2002 | 178 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2002 | 167 | 0.010 |
Why?
|
| Vacuoles | 1 | 2001 | 36 | 0.010 |
Why?
|
| Propanolamines | 1 | 2001 | 97 | 0.010 |
Why?
|
| Factor For Inversion Stimulation Protein | 1 | 1999 | 1 | 0.010 |
Why?
|
| Integration Host Factors | 1 | 1999 | 13 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 1999 | 33 | 0.010 |
Why?
|
| DNA Gyrase | 1 | 1999 | 12 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2001 | 377 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 198 | 0.010 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 1999 | 43 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 399 | 0.010 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1999 | 56 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 1169 | 0.010 |
Why?
|
| Phenotype | 1 | 2001 | 3039 | 0.010 |
Why?
|
| Male | 1 | 2014 | 62757 | 0.000 |
Why?
|